Found: 12
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 33–38
Esimbekova A.R., Lapkina E.Z., Ruksha T.G.
Introduction. Among the heterogeneous population of tumor cells, there are so-called dormant and senescent cells located in the G0 phase of the cell cycle. The transition to the G0 phase is a stress response mediated, for example, by treatment with chemotherap…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020
Savkova A.V., Gerasimov A.V., Vasiliev G.V., Krasilnikov S.E., Gulyaeva L.F., Voitsitsky V.E.
Introduction. Multiple primary malignant neoplasms (MPMN) most often develop in individuals with a hereditary predisposition to oncological diseases. There are inherited allelic variants of oncogenes, tumor suppressor genes and their combinations which disrupt…
ОБЗОР2020
Ruksha T.G., Zemtsov D.S., Lavrentiev S.N., Palkina N.V., Yessimbekova A.R.
Cutaneous melanoma is a highly heterogeneous malignancy, which characterized by low effectiveness of chemotherapeutic antitumor agents. 50% of melanomas have a somatic mutation in BRAF oncogene, leading to uncontrolled activation of mitogen-activated protein k…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018
Bazhenova L.G., Gulyayeva L.F., Shramko S.V.
Introduction. Myoma occupies a leading place in the structure of gynecological diseases, reduces the fertility rate and living standardsin females of reproductive age. In 85% cases myoma is combined with adenomyosis, which complicates the treatment and increas…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018
Saakyan S.V., Tsygankov A.Iu., Amiryan A.G., Loginov V.I., Burdennyy A.M.
Introduction. Uveal melanoma (UM) is a tumor of neuroectodermal origin developing from melanocytes of the uveal tract. The very common pathological characteristic of UM is its metastatic activity in liver, leading to the poor efficiency of the treatment. That`…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016
Mukhammadiyeva G.F., Bakirov A.B., Karimov D.O., Bagautdinova E.G., Karimova L.K., Valeyeva E.T.
Introduction. Determination of the role of genetic markers in the formation of individual susceptibility to the effects of harmful chemicals both opens up new possibilities for assessing the risk of occupational and production-related diseases and address prev…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Smal M.P., Rolevich A.I., Nabebina T.I., Krasny S.A., Goncharova R.I.
Introduction. Mutations in the tumor suppressor gene TP53 are observed approximately in the half of all human malignancies. In bladder cancer (BC), ТР53 molecular alterations were shown to be associated with more aggressive tumor phenotype; however their clini…
Research article2014
Loginov V.I., Pronina I.V., Burdennyy A.M., Khodyrev D.S., Kazubskaya T.P., Braga E.A., Kubatiev A.A., Kushlinskii N.E.
Introduction. Epigenetic changes caused by methylation in promoter CpG-islands are a fine and dynamic mechanism of gene expression regulation in tumors. Increased and decreased expression and alterations in the methylation status of the gene are considered to …
Research article2014
Chesnokov M.S., Lazarevich N.L.
Introduction. Pancreatic ductal adenocarcinoma (PDAC) is notable for its high aggressiveness and low efficiency of diagnostic and treatment approaches. Nuclear receptor HNF4α is one of the possible regulators of the development and differentiation of pancreati…
Research article2014
Gonzalgo M., Ishkhanova G.
Introduction.Transitional cell carcinoma of the bladder is the second most common malignancy of the genitourinary tract. Cystoscopy and urine cytology are the traditional most used techniques for diagnosis and surveillance of superficial bladder cancer. Urinec…
Research article2013
Paltseva E.M., Sekacheva M.I., Samofalova O.Yu., Kozmin L.D., Fedorov D.N.
The prognosis of one of the most commonly occurring malignancies worldwide – colorectal cancer (CRC) – depends on the development of disease recurrence and distant metastases, most frequently detected in the liver. The aim of our research was to study the asso…
Research article2013
Babayan A.Yu., Zaletaev D.V., Nemtsova M.V.
The paper presents the results of our own investigation of abnormal methylation of tumor suppressor genes RASSF1A, P16, CDH1, LAMC3, DAPK in tumors and non-tumor tissues obtained from 64 patients with superficial bladder cancer. The purpose of the research is …